Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Suzanne Lentzsch
Myeloma
Sigurður Kristinsson
Smoldering myeloma
Tanya Siddiqi
clinical trial access
Christopher Flowers
clinical trial access
Qing Yi
Novel CAR-T
Mala Shanmugam
myeloma
Jing Fu
myeloma
Simona Colla
Myeloma biology
Fenghuang Zhan
Myeloma and bone disease
Matteo Bellone
Smoldering multiple myeloma
Eugenio Morelli
Myeloma
Ruben Carrasco
Myeloma
Madhav Dhodapkar
multiple myeloma immunotherapy
Jianhua Yu
myeloma immunotherapy
Michaela Reagan
Multiple Myeloma
Noemí Puig Morón
Myeloma
Jing Yang
Myeloma
Alec Zhang
myeloma, immunotherapy
Bruno Paiva
smoldering myeloma
Nizar Bahlis
Myeloma immunotherapy
Amin Sobh
Myeloma biology
Carl June
CAR T immunotherapy
Lawrence Boise
CART and myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Peter Croucher
Multiple Myeloma
John Leonard
lymphoma research
Alfred Garfall
myeloma immunotherapy
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
F. Lennie Wong
Equity in Access
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Gareth Morgan
smoldering myeloma, MGUS
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Sham Mailankody
Myeloma immunotherapy clinical trials
William Matsui
Myeloma
Ricky Johnstone
lymphoma and myeloma
Jonathan Licht
DNA biology, myeloma
Brian Walker
smoldering myeloma, MGUS
Siegfried Janz
Myeloma immunotherapy
Caroline Arber
myeloma CAR-T
Paul Beavis
immunotherapy in myeloma
Jun Qi
Myeloma
Lev Kats
myeloma and epigenetics
Armin Rashidi
gut bacteria and transplant success